FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property

FMC (NYSE:FMC) entered a framework agreement to sell its Newark, Delaware property for about $114 million, with a planned leaseback of active facilities.

Rhea-AI Summary

FMC (NYSE:FMC) entered a framework agreement to sell its Newark, Delaware property for about $114 million, with a planned leaseback of active facilities. Proceeds are intended for debt reduction while retaining core R&D operations at the Stine Research Center. Closing is targeted for Q4 2026 but is not assured.

Positive

• Framework sale of Newark property for approximately $114 million
• Proceeds intended to be applied directly to debt reduction
• Company retains core R&D operations at Stine Research Center
• Underutilized real estate converted into capital while preserving research capabilities

Negative

• Transaction subject to due diligence and conditions; closing in Q4 2026 not assured
• Leaseback and other key operational and economic terms remain preliminary and unsettled

Argus Jun 23 session

-0.09% close to close Open Argus

Details

News Market Reaction – FMC

On Jun 23, the day this news came out, FMC closed 0.09% below the previous close.

Data tracked by StockTitan Argus for the Jun 23 session.

Key Figures

Sale-leaseback proceeds: $114 million Expected closing: Q4 2026 India divestiture value: $252 million +5 more

Sale-leaseback proceeds

$114 million

Gross proceeds from Newark, Delaware property framework agreement

Expected closing

Q4 2026

Target closing period for Newark sale-leaseback, subject to conditions

India divestiture value

$252 million

Agreed sale price for FMC India Private Limited business

Rimisoxafen prepayment

$200 million

Prepurchase payment under supply and license agreement with Corteva

New notes issuance

$1.2 billion

Aggregate principal of 8.000% senior secured notes due 2031

Expected net proceeds

$1.185 billion

Net proceeds from 8.000% senior secured notes offering

AQR ownership stake

7.41%

Beneficial ownership of FMC common stock per Schedule 13G filing

CEO tax disposition

34,177 shares

Shares withheld to cover taxes on 74,314 vested shares on June 11, 2026

Historical Context

5 past events · Latest: Jun 16

5 events

1. Jun 16

   Licensing agreement

   24h Move

   +3.3%

   Co-exclusive rimisoxafen deal with $200M prepurchase payment and future sales.

2. Jun 10

   Conference appearance

   24h Move

   +4.3%

   CEO and CFO scheduled remarks at Wolfe Research investor conference.

3. May 26

   Conference appearance

   24h Move

   +4.1%

   CFO participation in Wells Fargo Industrials & Materials Conference.

4. May 11

   Conference appearance

   24h Move

   -2.2%

   CEO and CFO presenting at BMO Global Farm to Market Chemicals Conference.

5. May 07

   Business divestiture

   24h Move

   -7.5%

   Agreement to sell India commercial business for $252M with proceeds to debt reduction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

sale-leaseback, framework agreement, due diligence period, senior secured notes, +2 more

6 terms

sale-leaseback financial

"entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD ... intends to lease back the facilities"

A sale-leaseback is a deal where an owner sells an asset—commonly real estate or equipment—to another party and immediately rents it back so they can keep using it. For investors, it matters because the seller converts a fixed asset into cash without disrupting operations, which can boost liquidity or pay down debt but also creates ongoing lease payments and long-term obligations that affect cash flow and the balance sheet.

framework agreement regulatory

"today announced that it has entered into a framework agreement to sell its property in Newark, Delaware"

A framework agreement is a standing contract that lays out general rules, pricing ranges, and how the parties will work together when they later sign specific orders or projects — like an umbrella that covers future deals without fixing every detail up front. Investors watch these because they make future revenue more predictable, can speed up repeat business, and may signal the scale or stability of upcoming sales, reducing uncertainty about a company’s growth.

due diligence period regulatory

"gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions"

The due diligence period is a set window of time after a deal is announced when buyers, investors or lenders closely check financial records, contracts, operations and risks before finalizing the transaction. Like the inspection and paperwork stage before buying a house, it matters to investors because issues found during this time can change the price, the terms, or lead to walking away, directly affecting the investment’s value and risk.

senior secured notes financial

"completed a private offering of $1.2 billion of 8.000% Senior Secured Notes due 2031"

Senior secured notes are loans a company sells to investors that are backed by specific assets and given first priority for repayment if the company defaults. Because they have a claim on collateral and are paid before other debts, they usually offer lower risk and correspondingly lower interest than unsecured debt; investors use them to judge how safe repayment and recovery of principal might be, like holding a mortgage instead of an unsecured credit card balance.

first-priority liens regulatory

"secured by first‑priority liens on substantial company and subsidiary assets"

A first-priority lien is a legal claim that gives a lender or creditor the first right to specific assets if a borrower cannot pay, meaning they are first in line to be repaid from those assets. For investors, that higher claim lowers the lender’s risk and usually affects interest rates and recovery expectations—similar to having the front seat in a queue to get paid back if the borrower defaults.

schedule 13g regulatory

"reported a Schedule 13G showing AQR Capital affiliates beneficially own 9,261,783 shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company will continue to operate its global R&D headquarters at the Stine Research Center

PHILADELPHIA, June 23, 2026 /PRNewswire/ --

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that it has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement. FMC will retain ownership of its adjacent Maryland properties.

The decision to pursue this transaction reflects FMC's ongoing efforts to optimize its asset base, converting underutilized real estate into capital that will be applied directly to debt reduction while maintaining the operational capabilities central to the company's growth strategy.

The transaction is structured to minimize any disruption to FMC's research operations. FMC's Stine Research Center, its global R&D headquarters, will continue to operate at the site following the transaction. The company's R&D capabilities, core research activities and scientific infrastructure remain fully in place.

"The Stine Research Center remains the global headquarters for FMC's R&D organization and will continue to play a central role in advancing our innovation pipeline," said Seva Rostovtsev, executive vice president and chief technology officer. "This transaction allows us to optimize our physical footprint by reducing underutilized space while preserving and improving the world-class facilities, infrastructure and scientific talent that power our research and long-term growth."

"Unlocking the value of underutilized real estate and applying the proceeds to debt reduction reflects our ongoing commitment to strengthening our balance sheet without compromising the investments and capabilities that will drive FMC's future growth," said Andrew Sandifer, executive vice president and chief financial officer.

The transaction is expected to close in the fourth quarter of 2026, subject to a due diligence period and various other closing conditions and adjustments. As is customary for transactions of this kind, the parties may elect to renegotiate certain terms during the diligence period and to amend the framework agreement accordingly. The agreement also contemplates that the form of the leaseback agreement and various other operational and economic terms are still to be agreed between the parties and are therefore at a preliminary stage. As a result, there can be no assurance that the framework agreement will ultimately result in any transaction.

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn^®.

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, regarding the agreement, the ability to negotiate a leaseback agreement, any impact on FMC's research operations, and the expected timing of and proceeds from the transaction.

In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  Forward-looking statements are qualified in their entirety by the above cautionary statement.

We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-announces-114-million-sale-leaseback-of-newark-delaware-property-302806783.html

SOURCE FMC Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did FMC (NYSE:FMC) announce about its Newark, Delaware property on June 23, 2026?

FMC announced a framework agreement to sell its Newark, Delaware property for about $114 million. According to FMC, the company plans to lease back actively used facilities and direct sale proceeds toward debt reduction, subject to due diligence and closing conditions.

How much cash will FMC (NYSE:FMC) receive from the Newark property sale-leaseback?

FMC expects gross proceeds of approximately $114 million from the Newark property sale. According to FMC, this capital is intended to help reduce debt while converting underutilized real estate into funds, with operations at the Stine Research Center continuing on site.

How will the FMC (NYSE:FMC) Newark sale-leaseback affect its R&D at Stine Research Center?

FMC expects its Stine Research Center R&D headquarters to keep operating at the Newark site. According to FMC, core research activities, scientific infrastructure, and R&D capabilities are planned to remain in place under a leaseback of actively used facilities.

When is the FMC (NYSE:FMC) Newark, Delaware property transaction expected to close?

FMC targets closing the Newark property transaction in the fourth quarter of 2026. According to FMC, completion depends on a due diligence period, various closing conditions, and agreement on leaseback and operational terms, so there is no assurance the deal will finalize.

How does the FMC (NYSE:FMC) Newark property sale support its balance sheet?

FMC plans to apply Newark sale proceeds directly to debt reduction to support its balance sheet. According to FMC, unlocking value from underutilized real estate aligns with efforts to strengthen finances without compromising key R&D investments and long-term growth capabilities.

What are the main risks and uncertainties of the FMC (NYSE:FMC) Newark sale-leaseback?

The Newark sale-leaseback remains a framework agreement that may not result in a transaction. According to FMC, due diligence, renegotiation of terms, and still-preliminary leaseback and operational details mean closing in Q4 2026 cannot be assured.